Distinguished in Chronic Lymphocytic Leukemia (CLL)

Krzysztof Jamroziak

Smoluchowskiego 25 Str, 
Wroclaw, DS, PL 
Distinguished in Chronic Lymphocytic Leukemia (CLL)
Smoluchowskiego 25 Str, 
Wroclaw, DS, PL 
OverviewLocationsClinical Research

Overview

Krzysztof Jamroziak practices in Wroclaw, Poland. Mr. Jamroziak is rated as a Distinguished expert by MediFind in the treatment of Chronic Lymphocytic Leukemia (CLL). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Multiple Myeloma, Leukemia, and Bone Marrow Transplant.

His clinical research consists of co-authoring 132 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 30 articles in the study of Chronic Lymphocytic Leukemia (CLL).

Gender
Male

Locations

Smoluchowskiego 25 Str, Wroclaw, DS 50370, Poland
Other Locations
Chocimska 5 Street, Warsaw, MZ 00791, Poland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

An Open-Label, Phase 1/2 Study of Melflufen and Dexamethasone for Patients With AL Amyloidosis Following at Least One Prior Line of Therapy
An Open-Label, Phase 1/2 Study of Melflufen and Dexamethasone for Patients With AL Amyloidosis Following at Least One Prior Line of Therapy
Enrollment Status: Terminated
Publish Date: March 28, 2022
Intervention Type: Drug
Study Drugs: Melphalan-Flufenamide (Melflufen), Dexamethasone
Study Phase: Phase 1

132 Total Publications

Microstructural and Impact Resistance Optimization of Concrete Composites with Waste-Based Aggregate Substitutions.
Microstructural and Impact Resistance Optimization of Concrete Composites with Waste-Based Aggregate Substitutions.
Journal: Polymers
Published: August 20, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Jamroziak's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 20 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile